Learning Objectives


  • Learning Objective 1: Discuss the current standard of care for adjuvant therapy and for systemic therapy in advanced/metastatic cholangiocarcinoma
  • Learning Objective 2: Describe the role for immunotherapy in cholangiocarcinoma
  • Learning Objective 3: Describe the genomic landscape of cholangiocarcinoma and emerging targeted therapies


Session date: 
08/09/2019 - 12:30pm to 1:30pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Andy Chih-Yi Liao, MD